Hemodynamic basis for glomerular injury in rats with desoxycorticosterone-salt hypertension.
about
Modulation of Immunity and Inflammation by the Mineralocorticoid Receptor and AldosteroneRenal autoregulation in health and diseaseRelationship of and cross-talk between physical and biologic properties of the glomerulusControl of glomerular hypertension limits glomerular injury in rats with reduced renal massTherapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the ratBiochemical and Cellular Determinants of Renal Glomerular ElasticityIntrarenal hemodynamics in primary aldosteronism before and after treatment.Ontogenetic aspects of hypertension development: analysis in the rat.Glomerular injury in uninephrectomized spontaneously hypertensive rats. A consequence of glomerular capillary hypertension.Dietary protein restriction in established renal injury in the rat. Selective role of glomerular capillary pressure in progressive glomerular dysfunction.Control of glomerular hypertension by insulin administration in diabetic rats.Diseased renal glomeruli are getting soft. Focus on "Biophysical properties of normal and diseased renal glomeruli"Biophysical properties of normal and diseased renal glomeruli.Glomerular sclerosis is prevented during urinary tract obstruction due to podocyte protectionLongitudinal study of living kidney donor glomerular dynamics after nephrectomy.Serum phosphorus predicts incident chronic kidney disease and end-stage renal diseaseChronic glucocorticoid therapy amplifies glomerular injury in rats with renal ablation.Nitric oxide and angiotensin II. Glomerular and tubular interaction in the ratThe association of predonation hypertension with glomerular function and number in older living kidney donors.Prevention of 11-deoxycorticosterone-salt-induced glomerular hypertrophy and glomerulosclerosis by dietary phosphate binderA simple indentation device for measuring micrometer-scale tissue stiffness.Role of aldosterone in the remnant kidney model in the rat.Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathyCardiovascular and renal damage in primary aldosteronism: outcomes after treatment.The podocyte slit diaphragm--from a thin grey line to a complex signalling hub.A potential role for mechanical forces in the detachment of podocytes and the progression of CKD.Treatment of Primary Aldosteronism and Organ Protection.Stressed podocytes-mechanical forces, sensors, signaling and response.The Gordon Wilson lecture. Why kidneys fail: an unifying hypothesis.The aging kidney: structure, function, mechanisms, and therapeutic implications.The benefits of ACE inhibitors and calcium antagonists in slowing progressive renal failure: focus on fixed-dose combination antihypertensive therapy.Effect of prolonged administration of a urinary kinase inhibitor, ebelactone B on the development of deoxycorticosterone acetate-salt hypertension in rats.Cytoskeletal changes in podocytes associated with foot process effacement in Masugi nephritis.Complex glomerular pathology of thrombotic microangiopathy and focal segmental glomerulosclerosis forms tumor-like mass in a renal transplant donor with severe renovascular hypertension.Applied pressure enhances cell proliferation through mitogen-activated protein kinase activation in mesangial cells.The alpha8 integrin chain affords mechanical stability to the glomerular capillary tuft in hypertensive glomerular disease.Anti-hypertension effects of traditional Chinese medicine ju-ling-tang on renal hypertensive rats.Role of fibrillin-1 in hypertensive and diabetic glomerular disease.Relationship between subtle urinary albumin excretion and risk of incident hypertension: modification by glomerular filtration rate.NO inhibits stretch-induced MAPK activity by cytoskeletal disruption.
P2860
Q26785911-49E40F56-C6C1-411B-A1AB-F4FFF392FBD2Q28082365-B298385D-D1AC-4505-B46F-D886A76CC15EQ28083461-71FF20B5-2837-4777-AED1-48A4558F3157Q28360314-E5B747CE-BCBC-4376-84B7-7B61A8F942E1Q28360398-959B9E8D-5FA9-49A4-9CEA-1C8E2311CC53Q28554988-7C619C94-A092-44DA-93E2-50306E7CA7C3Q30482375-7602933F-CF74-4EE1-95B2-94AFF39796B8Q33744642-1C285B3C-01EE-43A8-BB15-66A2B63550C6Q34526945-076E292E-0643-4F98-B06D-635F0101841FQ34545813-8D792128-84EA-4258-AF3D-3350C5360125Q34571180-E1037144-7403-4383-B8C5-C28EA31EF94AQ34717928-43AF8A6A-53E8-4353-973E-8CCB39193B28Q34717990-6771873E-8218-4DD2-A94D-A83FD6CF81CCQ34719120-F86FED68-F1B7-469E-946E-89843BCDB37EQ35183906-4D31C1A3-EF5C-4410-ACB8-7B3EBB64F7ADQ35218230-F834B67F-1828-40F8-AD8F-031E5F7FE1CBQ35579156-65F81FB4-AC07-4FF6-BA30-A7BE95A83F61Q35600824-961A7522-F55D-4FE4-B0C6-FB07612AEBB0Q35658596-A005C775-2EA9-4E33-86F4-E189F3D73B71Q35811445-78BDC970-98E8-4F43-AAE3-196B3EF0A2F2Q36085213-FB20F40B-2B1F-485E-BC8E-74F2E425DDD2Q37358980-64CA3F46-CBDA-4E30-8274-8F113571DEC7Q37531744-7D6C090E-6CA8-4261-9FD1-E63FA770F386Q37779717-DF3F9B88-C65C-41AD-BC23-7C46DDA3BA26Q38133715-7A6C710A-1744-4E28-A64C-2D7691020A9EQ38233673-769FC4C1-558F-42ED-B6A5-00A9471234D4Q38527834-E0B15230-4A1B-4CC5-9A62-7235B6FDE5B2Q38661145-2C8A6D9B-51CC-4BA7-8198-34BE5164A2E8Q39664334-2C40299F-7A40-4D42-9D02-2CA7426961E9Q39765048-23DC2CA9-C223-4D0E-A505-6DA7F0193B1BQ41249165-A5429E4A-1E27-420B-825D-89A2CB647E45Q42004761-396AA794-1E4D-46C4-AD22-E2232417A622Q42049689-187A6ED9-F450-4967-BF0E-22B0F577CF5DQ42104713-FD748C8F-033A-48F7-9FE7-5ED0A2C923C6Q42457313-898ADED9-3CC4-441B-9591-94088D1FB647Q42794553-84C322AD-DDCB-4953-8EE9-7877A0C2AAE9Q46851788-6BB1BE79-4583-4BB3-94A5-259B6754190BQ46870146-B692F0A1-C1F5-436F-99E0-0EFA15C6C946Q47949598-D9F67463-C059-47D5-897E-A8074BC1DABDQ52540952-67312D2D-DA36-4937-9C28-B68D611DA030
P2860
Hemodynamic basis for glomerular injury in rats with desoxycorticosterone-salt hypertension.
description
1984 nî lūn-bûn
@nan
1984 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1984 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1984年の論文
@ja
1984年学术文章
@wuu
1984年学术文章
@zh-cn
1984年学术文章
@zh-hans
1984年学术文章
@zh-my
1984年学术文章
@zh-sg
1984年學術文章
@yue
name
Hemodynamic basis for glomerul ...... ticosterone-salt hypertension.
@ast
Hemodynamic basis for glomerul ...... ticosterone-salt hypertension.
@en
Hemodynamic basis for glomerul ...... ticosterone-salt hypertension.
@nl
type
label
Hemodynamic basis for glomerul ...... ticosterone-salt hypertension.
@ast
Hemodynamic basis for glomerul ...... ticosterone-salt hypertension.
@en
Hemodynamic basis for glomerul ...... ticosterone-salt hypertension.
@nl
prefLabel
Hemodynamic basis for glomerul ...... ticosterone-salt hypertension.
@ast
Hemodynamic basis for glomerul ...... ticosterone-salt hypertension.
@en
Hemodynamic basis for glomerul ...... ticosterone-salt hypertension.
@nl
P2093
P2860
P356
P1476
Hemodynamic basis for glomerul ...... ticosterone-salt hypertension.
@en
P2093
B M Brenner
H G Rennke
L D Dworkin
T H Hostetter
P2860
P304
P356
10.1172/JCI111349
P407
P577
1984-05-01T00:00:00Z